Telix Completes Acquisition of Atlab for Prostate Cancer Program
Go back to Telix Completes Acquisition of Atlab for Prostate Cancer Program| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 9.96 -0.14 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.10 | 52 Week High | $2.18 | |||
| Open | $10.04 | 52 Week Low | $0.30 | |||
| Day High | $10.04 | P/E | N/A | |||
| Day Low | $9.94 | EPS | $-3.32 | |||
| Volume | 18,171 | |||||

